MeSH term
Frequency | Condition_Probility | Alleles | 8 | 0.0 |
*Body Mass Index | 2 | 2.0 |
Carrier Proteins/*genetics | 17 | 1.0 |
Female | 32 | 0.0 |
Gene Frequency | 15 | 0.0 |
Humans | 46 | 0.0 |
*Linkage (Genetics) | 4 | 0.0 |
Male | 27 | 0.0 |
Obesity/genetics | 4 | 7.0 |
*Polymorphism, Genetic | 12 | 0.0 |
*Receptors, Cell Surface | 22 | 5.0 |
Regression Analysis | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 17 | 0.0 |
Adolescent | 6 | 0.0 |
Adult | 27 | 0.0 |
Basal Metabolism | 2 | 4.0 |
Body Composition | 5 | 2.0 |
Body Mass Index | 16 | 1.0 |
Genotype | 23 | 0.0 |
Leptin/*blood | 4 | 5.0 |
Middle Aged | 17 | 0.0 |
Research Support, Non-U.S. Gov't | 33 | 0.0 |
English Abstract | 5 | 0.0 |
Adipose Tissue | 4 | 7.0 |
Anthropometry | 2 | 0.0 |
Australia | 2 | 1.0 |
Carrier Proteins/genetics | 4 | 1.0 |
Leptin/genetics | 2 | 18.0 |
Obesity/*genetics | 9 | 7.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Prospective Studies | 2 | 0.0 |
*Variation (Genetics) | 3 | 0.0 |
Age Factors | 2 | 0.0 |
Aged | 6 | 0.0 |
Exons | 6 | 0.0 |
Family Health | 2 | 0.0 |
Introns | 5 | 0.0 |
Phenotype | 8 | 0.0 |
Child | 2 | 0.0 |
Receptors, Cell Surface/*genetics | 13 | 4.0 |
Blood Glucose/metabolism | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Cohort Studies | 2 | 0.0 |
Polymorphism, Genetic | 4 | 0.0 |
European Continental Ancestry Group/genetics | 3 | 0.0 |
Base Sequence | 9 | 0.0 |
Insulin/blood | 4 | 0.0 |
Twins, Monozygotic | 2 | 2.0 |
Blood Glucose/analysis | 2 | 0.0 |
Exons/genetics | 3 | 0.0 |
Leptin/blood/*genetics | 2 | 40.0 |
Lipids/blood | 2 | 0.0 |
Proteins/*metabolism | 3 | 0.0 |
Animals | 10 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
Receptors, Cell Surface/*genetics/metabolism | 2 | 2.0 |
Case-Control Studies | 5 | 0.0 |
DNA/genetics | 2 | 0.0 |
Leptin/*genetics | 3 | 27.0 |
Odds Ratio | 3 | 0.0 |
Chromosomes, Human, Pair 1 | 3 | 1.0 |
Genome, Human | 2 | 0.0 |
Insulin Resistance/*genetics | 2 | 2.0 |
Lod Score | 2 | 0.0 |
Microsatellite Repeats | 2 | 0.0 |
Netherlands | 2 | 1.0 |
Obesity/*genetics/metabolism | 2 | 14.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Leptin | 5 | 4.0 |
Quebec | 2 | 3.0 |
Polymorphism, Genetic/*physiology | 2 | 2.0 |
Comparative Study | 4 | 0.0 |
Estrogen Receptor alpha | 2 | 0.0 |
Receptors, Cell Surface/genetics | 3 | 2.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Mice | 4 | 0.0 |
Sex Characteristics | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Energy Metabolism/*genetics | 2 | 13.0 |
Amino Acid Sequence | 3 | 0.0 |
Receptors, Cytokine/*genetics | 3 | 5.0 |
Rats | 2 | 0.0 |
Swine/*genetics | 2 | 1.0 |
Haplotypes | 2 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
